Education
About Us
Working with TipRanks
Follow Us
Sarah Howell Insider Profile
4 Followers
Sarah Howell, Chief Executive Officer at Arecor Therapeutics PLC, holds 905.48K shares in Arecor Therapeutics PLC (Ticker: GB:AREC). Most recently, Sarah Howell Bought 21,077p shares of Arecor Therapeutics PLC on May 21, 2025 for an estimated value of 9.90K.
Sarah Howell Arecor Therapeutics PLC (AREC)Chief Executive Officer
Arecor Therapeutics PLC (AREC)
Chief Executive Officer
Ranked #77,595 out of 102,551 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-23.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Sarah Howell holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sarah Howell
Sarah Howell's Trading History
List of latest transactions for each holding click on a transaction to see Sarah Howell's performance on stock
You May Also Like
Sarah Howell insider profile FAQ
What is the percentage of profitable transactions made by Sarah Howell?
The percentage of profitable transactions made by Sarah Howell is 33%.
What is the average return per transaction made by Sarah Howell?
The average return per transaction made by Sarah Howell is -23.90%.
What stocks does Sarah Howell hold?
Sarah Howell holds: GB:AREC stocks.
What was Sarah Howell’s latest transaction?
Sarah Howell latest transaction was an Informative Buy of 9.90K.
What was Sarah Howell's most profitable transaction?
Sarah Howell’s most profitable transaction was an Informative Buy of GB:AREC stock on May 21, 2025. The return on the trade was 14.20%.
What is Sarah Howell's role in Arecor Therapeutics PLC?
Sarah Howell's role in Arecor Therapeutics PLC is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.